Sucralose

This is one of the most discussed current concerns, but the human evidence is still inconsistent. A 2024 review of clinical trials on low- and no-calorie sweeteners found only two of five human trials reported meaningful microbiome changes, with results varying by sweetener, dose, duration, and participant characteristics. Some 2023-2024 papers suggest sucralose may shift specific gut or oral microbial patterns, but the evidence is not strong enough to say normal sucralose intake reliably "damages" the microbiome in everyone.

A 2025 review focused on sucralose and insulin response concluded intervention studies are inconsistent, with roughly half suggesting some adverse effect on insulin response or sensitivity and half finding little or none. Acute trials sometimes report altered insulin or incretin responses, especially when sucralose is taken before carbohydrate or in people with obesity, but other studies are neutral. The strongest current reading is not "sucralose spikes insulin" full stop; it is that any effect appears context-dependent and smaller than online discourse often implies.

When sucralose replaces sugar rather than being added on top of an already high-calorie diet, randomized trials generally show lower short-term calorie intake and neutral-to-slightly better weight outcomes than sugar. A 2019 randomized trial comparing several low-calorie sweeteners found sucrose increased body weight more than sucralose over time, and broader meta-analyses of low- and no-calorie sweetened beverages point the same way when they substitute for sugary drinks. The benefit here comes from displacing sugar calories, not from sucralose having a special fat-burning effect.

This fear persists, but the current human evidence does not show a clear carcinogenic signal from normal sucralose intake. EFSA's re-evaluation published on 16 February 2026 kept the acceptable daily intake at 15 mg/kg body weight per day and concluded current estimated exposure is below that threshold across population groups assessed. That is not proof of zero risk in every imaginable scenario, but it does mean the popular claim that ordinary dietary sucralose intake is clearly carcinogenic is not supported by current regulatory review and human evidence.

This is the main newer caution flag. Laboratory work published in 2024 found sucralose can degrade under prolonged heating and form chlorinated sugar breakdown products, especially in baking-style model systems or in the presence of protein. EFSA's February 2026 re-evaluation said this uncertainty matters for proposed new high-heat uses and for home baking or frying, even while current authorised uses remain within safety limits. What is established is chemical breakdown under some conditions; what is not established is the size of any real-world health risk from occasional domestic use.

Some cohort studies link diet drinks and artificial sweetener use with higher body weight, type 2 diabetes, or poorer cardiometabolic outcomes. But those findings are hard to interpret because people already trying to lose weight or manage blood sugar are more likely to choose diet products in the first place. Randomized trials usually do not show sucralose itself causing weight gain, and often show the opposite when it replaces sugar. So the association is real in observational data, but it should not be treated as proof that sucralose directly drives weight gain.

For most people, the bigger question is what sucralose is doing in the diet. Swapping one sugary drink for a sucralose-sweetened version can reduce added sugar intake; building a diet around very sweet ultra-processed foods is a different pattern entirely. Trials and cohort data alike suggest substitution, total energy intake, fibre intake, and overall diet quality matter more than one sweetener viewed in isolation. Least Processed's practical lens is that sucralose may matter some, but the surrounding diet and food pattern matter more.